FindTrial
Sign In

HP802-247

BIOLOGICAL8 trials

Sponsors

Healthpoint

Conditions

Dystrophic Epidermolysis BullosaNon-melanoma Skin CancerNormal Female VolunteersUlcerVenous Leg UlcerVenous Leg UlcersVenous Stasis UlcerVenous Stasis Ulcers

Phase 1

Study of Survival Duration for Donor Skin Cells in Skin Biopsy Wounds
CompletedNCT01190865
HealthpointNormal Female Volunteers
Start: 2010-09-30End: 2010-12-31Updated: 2017-07-02

Phase 2

Dose Finding Study of HP802-247 in Venous Leg Ulcers
CompletedNCT00852995
HealthpointVenous Leg Ulcer, Venous Stasis Ulcers
Start: 2009-02-28End: 2011-07-31Updated: 2016-10-24
Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients
CompletedNCT01359735
HealthpointNon-melanoma Skin Cancer
Start: 2011-05-31End: 2012-05-31Updated: 2017-06-29
A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa
WithdrawnNCT01528306
HealthpointDystrophic Epidermolysis Bullosa
Start: 2012-03-31End: 2013-07-31Updated: 2012-05-16
A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers
TerminatedNCT02154087
HealthpointVenous Leg Ulcers
Start: 2014-07-31End: 2015-10-31Updated: 2016-10-03

Phase 3

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2
CompletedNCT01737762
HealthpointVenous Leg Ulcers
Start: 2012-11-30End: 2015-11-30Updated: 2017-07-26
Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers
TerminatedNCT01853384
HealthpointUlcer, Venous Stasis Ulcer, Venous Ulcer
Start: 2013-11-30End: 2015-02-28Updated: 2016-10-03

Unknown Phase

Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg Ulcer
NCT01658618
HealthpointVenous Leg Ulcer
Start: 2012-09-30End: 2015-05-31Target: 440Updated: 2014-02-03

Related Papers

Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial.
2012-08-03112 citations